<DOC>
	<DOC>NCT00523419</DOC>
	<brief_summary>The primary purpose of your participation in this study is to help answer the following research questions, and not to provide you treatment for your condition. - To assess how well treatment with pemetrexed works for patients with your type of cancer - To assess for any side effects that might be associated with pemetrexed. - To look at the characteristics and levels of certain of your genes and proteins to learn more about osteosarcoma and how pemetrexed works in your body.</brief_summary>
	<brief_title>Chemotherapy for Patients With Osteosarcoma</brief_title>
	<detailed_description />
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Histological diagnosis of high grade locally advanced or metastatic osteosarcoma Must have one prior chemotherapy regimen for advanced disease At least 1 unidimensional measurable lesion by computed tomography (CT) scan Have a good performance status Adequate organ function Have a serious concomitant systemic disorder (for example active Human Immunodeficiency Virus infection) Have brain metastases not adequately treated Significant weight loss (that is more than 20%) over the previous 6 weeks before study entry Inability or unwillingness to take folic acid or vitamin B12 supplementation and corticosteroids Pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>